Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2016-001383-10-NL
EUCTR2016-001383-10-NL
Active, not recruiting
Phase 1

Evaluating the effect of short term withdrawal of PPI's in patients for reducing stomach wall uptake with 99mTc Sestamibi for myocardial perfusion imaging

Rijnstate ziekenhuis0 sitesJune 27, 2016
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
DrugsOmeprazole ATC code: A02BC01

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Rijnstate ziekenhuis
Status
Active, not recruiting
Last Updated
9 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 27, 2016
End Date
TBD
Last Updated
9 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Rijnstate ziekenhuis

Eligibility Criteria

Inclusion Criteria

  • •\- Patients who have a referral from a cardiologist to a myocardial perfusion imaging.
  • •\- Patients older than 18 years.
  • •\- Patients wherein for the myocardial perfusion during exercise use is made of the administration of adenosine or regadenoson.
  • •\- Patients taking preventive use of PPIs.
  • •\- Patients who have signed an informed consent.
  • •\- Patients taking PPIs for longer than two weeks.
  • •\- the scan is accomplished on the BrightView 1 in Nucleare department Rijnstate Arnhem.
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes

Exclusion Criteria

  • •\- myocardial perfusion stress test performed with a bycycle ergometry.
  • •\- Patients with dyspepsia.
  • •\- Patients with only uptake in the stomach cavity.
  • •\- Patients who are not prepared and tested in accordance with the protocols in the hospital Rijnstate.
  • •\- Patients with the following well\-known diseases, Zollinger Ellison Syndrome, a barrettoesofagus or a esophagitis with endoscopic grade C or D.
  • •\- Patients who are(partially) paravasal injected.
  • •\- Possible complications with concomitant medications.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Prospective study on the effects of withdrawal of anti-TNF therapy in patients with rheumatoid arthritis who are in remission- stop-studyRheumatoid arthritis10023213
NL-OMON34531Academisch Medisch Centrum40
Recruiting
Phase 2
Intensive care in mini omega bariatric surgery
IRCT20210614051574N6Esfahan University of Medical Sciences55
Not yet recruiting
Not Applicable
Evaluation of short term and long term effects of cochlear implantation on vestibular functioHealth Condition 1: H818- Other disorders of vestibular function
CTRI/2023/07/054709Department of ENT AND HNS,AIIMS DELHI
Active, not recruiting
Not Applicable
Instrumental and clinical effects of withdrawal of beta blockers therapy in patients with heart failure and right ventricular dysfunction'' - Destroheart failureMedDRA version: 14.1Level: LLTClassification code 10011949Term: Decompensation cardiacSystem Organ Class: 10007541 - Cardiac disordersTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2011-000890-29-ITFONDAZIONE CENTRO S. RAFFAELE DEL MONTE TABOR
Recruiting
Not Applicable
Investigation of the efficacy of a short-intervention implementing chairwork in patients with depressive disorders - a randomized controlled trial.F32.0F32.1F32.2F33.0F33.1F33.2Mild depressive episodeModerate depressive episodeSevere depressive episode without psychotic symptomsRecurrent depressive disorder, current episode mildRecurrent depressive disorder, current episode moderateRecurrent depressive disorder, current episode severe without psychotic symptoms
DRKS00031307Klinikum ChristophsbadChristophsbad, Akademie für Psychotherapie (C-AP), Forschungssektion für Angewandte Psychotherapie und Psychiatrie62